United Kingdom· GB-APID-37941911000001106
Dihydroergotamine 1mg/1ml solution for injection ampoules
A dihydroergotamine product containing dihydroergotamine, registered in United Kingdom by Imported (Canada). The same ATC class is registered in 8 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Dihydroergotamine is registered in 8 of 19 countries.
Countries holding a registration under ATC N02CA01 (dihydroergotamine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 6 of them publish a price we can compare per daily dose
Dihydroergotamine · ATC N02CA01
8 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Franceprice
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Dihydroergotamine
- Manufacturer
- Imported (Canada)
- Country
- United Kingdom (GB)
- ATC code
- N02CA01
- ATC class
- Dihydroergotamine
- Defined daily dose
- 1 mg, N
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
178 interactions on record for dihydroergotamine.
Graded by severity as the source publishes them — 54 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dihydroergotamine · interactions on record
178 records
- 54 severe
- 90 moderate
- 1 minor
- 17 info
Most severe, free to view
- EpinephrineA01AD01severe
- IsomethepteneA03AX10severe
- FenfluramineA08AA02severe
- DexfenfluramineA08AA04severe
16 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dihydroergotamine in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesATZUMISatsuma Pharmaceuticals, Inc.
- BelgiumDiergo Spray 4 mg/mlAmdipharm
- SwedenOrstanorm 2,5 mg TablettAmdipharm Limited
- CanadaDIHYDROERGOTAMINE (DHE), 1MG/MLSTERIMAX INC
- FinlandMigranalNovartis Finland Oy
- FranceDIERGOSPRAY 4 mg/ml, solution pour pulvérisation nasaleAMDIPHARM
- NorwayDihydroergotamine sterimax
- PolandDihydroergotaminum FilofarmFarmaceutyczna Spółdzielnia Pracy FILOFARM
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Austria · Dihydergot, Migranal
- Belgium · Diergo Spray
- France · Diergospray
- Greece · Dihydergot
- Italy · Diidergot, Dineza
- Poland · Dihydroergotaminum Filofarm
- Sweden · Orstanorm
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ccef1348-daf7-4316-9a44-31fad59035c4 GET /v1/drugs/ccef1348-daf7-4316-9a44-31fad59035c4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "37941911000001106",
"desc": "Dihydroergotamine 1mg/1ml solution for injection ampoules (Imported (Canada))",
"form": "Solution for injection",
"vpid": "39710111000001109",
"source": "dmd",
"vtm_id": "775595009",
"strength": "1 mg",
"substance": "Dihydroergotamine",
"ingredient": "Dihydroergotamine mesilate",
"supplier_code": "11820111000001109"
}See everything about dihydroergotamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.